Experiences with

Alzheimer's disease

It's often prescribed for people with Alzheimers but also for PD. She said nothing about Alzheimers Disease. Several years ago I filled my truck at a gas station then left without pulling my credit card out.

“We are at a pivotal moment in our company’s journey as we have entered the late clinical stages for both Alzheimer’s and Parkinson’s,” said Maria Maccecchini, Ph.D., Founder and CEO of Annovis Bio. “It is incredibly rewarding to see our work bring us here, once again supporting that our drug is efficacious

I saw this in the esteemed medical journal "The Daily Mail" https://www.dailymail.co.uk/sciencetech/article-14507379/Ingredient-hidden-spice-rack-completely-reverse-Alzheimers-disease.html "A compound hiding inside rosemary and sage has been turned into a new treatment that may reverse Alzheimer's disease

Alzheimers and Parkinson's appear to have a link AFAIK. Read the latest research and perhaps there's hope for dementia research in Parkinson's?

Hi all, Covered in the past, here is another, balanced view: https://www.brainhealthbreakthroughs.com/does-aspirin-prevent-alzheimers-disease Kind wishes to all J (-:

Hi all, Covered in the past, here is another, balanced view: https://www.brainhealthbreakthroughs.com/does-aspirin-prevent-alzheimers-disease Kind wishes to all J (-:

This interview is specifically about one Alzheimer's patient but does mention that the treatment and a ketogenic diet could help other similarconditions: https://youtu.be/r3-5GQfeJ68?si=S40GsCn93jMH5WIZ

https://www.science.org/content/blog-post/fraud-so-much-fraud I hope there is a criminal investigation.

"For decades, the prevailing theory in the field has stated that a protein made up of 42 amino acids called amyloid-beta 42 (Aβ42) hardens into clumps called amyloid plaques, and those plaques damage the brain, causing Alzheimer's disease."

Per Dr Matt: "A new paper about Alzheimer's, Parkinson's, ALS, and Huntington's was just published on 9/6/2024, which conceptualizes each of these as different facets of the same disease. It was written with the assistance of Martin Picard, a world leader in mitochondrial biology.

The pulses of light and sound, delivered at a frequency of 40 per second, or 40 hertz, jumpstarted the mice’s neurons to fire electrical signals in time with the pulses—and subsequently reduced the number of amyloid plaques and tau protein tangles in their brains, two hallmarks of Alzheimer’s disease

Dr Robert Sapolsky just posted an authoritative and helpful talk on YouTube which looks at possible causes of Alzheimer's, prospective treatments, and practical steps to minimise one's risk.I found it a fascinating and entertaining video. It probably has some relevance to Parkinson's, but in any case

We're demonstrating that by targeting the brain's metabolism, we can not only slow, but reverse the progression of this disease."

The researchers report that this particular combination (low magnesium levels and high amounts of homocysteine) “damages the body’s genes, making people more susceptible to Alzheimer’s and Parkinson’s disease, gastrointestinal diseases, a range of cancers, and diabetes”.

A drug used to induce labor in pregnant women has been shown to reactivate tiny waste-clearing pumps in the brains of old mice. The finding could hold promise as a new way to fight Alzheimer's and Parkinson's diseases and overall cognitive decline. https://newatlas.com/health-wellbeing/pregnancy-drug-brain

There has been interest in BPAP for potential clinical use in humans, including in the treatment of Parkinson's disease, Alzheimer's disease, and depression. There has also been interest in BPAP to help slow aging. https://en.wikipedia.org/wiki/Benzofuranylpropylaminopentane

Treatment designed to boost mitochondrial function-- New Zealand https://parkinsonsnewstoday.com/news/pretzel-advances-mitochondrial-therapy-px578-phase-1-trial/?utm_source=PAR&utm_campaign=530d83d996-Email_ENL_US_PAR&utm_medium=email&utm_term=0_62dd4fb5e3-530d83d996-74556474 Pretzel Therapeutics has

(NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative disorders such as Alzheimer’s Disease (AD) and Parkinson’s Disease (PD), announces the filing of the new composition of matter patent with the U.S.

(NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative disorders such as Alzheimer’s Disease (AD) and Parkinson’s Disease (PD), today announced that it will host an investor webcast to discuss recent developments

(NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative disorders such as Alzheimer’s Disease (AD) and Parkinson’s Disease (PD), today announced that it will host an investor webcast to discuss recent developments